Combining SGLT2 Inhibition With a Thiazolidinedione Additively Attenuate the Very Early Phase of Diabetic Nephropathy Progression in Type 2 Diabetes Mellitus

Although both sodium glucose co-transporter 2 inhibition by dapagliflozin and thiazolidinedione, pioglitazone have glucose-lowering and anti-inflammatory effects, the therapeutic efficacy of their combination on diabetic nephropathy has not been investigated. 9-week-old male db/db mice were randomly...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Eugene, Shin, Eugene, Kim, Gyuri, Lee, Ji-Yeon, Lee, Yong-ho, Lee, Byung-Wan, Kang, Eun Seok, Cha, Bong-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060671/
https://www.ncbi.nlm.nih.gov/pubmed/30072956
http://dx.doi.org/10.3389/fendo.2018.00412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060671/
https://www.ncbi.nlm.nih.gov/pubmed/30072956
http://dx.doi.org/10.3389/fendo.2018.00412

Ejemplares similares